Resource Logo
CDC HIV/AIDS/Viral Hepatitis/STD/TB Prevention News Update

GLOBAL: World Failing to Do Enough to Curb HIV, Study Shows


Australian Associated Press (03.01.10) - Tuesday, March 02,

HIV prevention and treatment service coverage for injecting drug users (IDUs) is too low in many countries to prevent transmission, a discrepancy that impacts infection rates at the local level, new research shows.

"Governments that have not made needle and syringe programs and opioid substitution available need to be convinced that these interventions are the most effective ways to stop HIV spreading among [IDUs], and to the wider community," said lead author Dr. Bradley Mathers of the University of New South Wales National Drug and Alcohol Research Center.

Australian health authorities distribute 213 clean needles per IDU each year, compared with 188 for the United Kingdom, 46 in Canada and 22 in the United States. In Russia, which has the second-largest IDU population after China, there is no methadone substitution. Other prevention measures among Russian IDUs are, similarly, virtually non-existent. HIV prevalence among Russian IDUs is 40 percent, versus just 1.5 percent among IDUs in Australia.

"Our high level of prevention in Australia has paid off with low levels of HIV infection among [IDUs] compared with countries with a similar level of injecting drug use," Mathers said.

Globally, just 8 percent of IDUs had access to a syringe exchange program last year, Mathers said. Coverage ranged from 100 percent in the Czech Republic and Ireland to less than 3 percent in China, Malaysia and Thailand. Opioid substitution therapy was available in only 70 of 151 countries with known IDU populations.

Only one of every 25 HIV-positive IDUs globally is receiving antiretroviral treatment. The worst treatment coverage was found in Kenya, Pakistan, and Russia.

The full report, "HIV Prevention, Treatment, and Care Services for People Who Inject Drugs: A Systematic Review of Global, Regional, and National Coverage," was published in The Lancet (2009;doi:10.1016/S0140-6736(10)60232-2).


Copyright © 2010 -CDC Prevention News Update, Publisher. All rights reserved to Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

Information in this article was accurate in March 2, 2010. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.